Diagnosis and Progression
Diagnosis and Progression

Diagnostic Hallmarks of AMD Progression to GA

Early AMD: Drusen Development Image courtesy of Dr. Mohammad Rafieetary.
Early AMD: Drusen Development

Drusen are a hallmark of early age-related macular degeneration (AMD), which can be observed by direct examination of CFP or
OCT.2-5 Drusen come in various sizes—the larger the drusen, the greater the chance of progression to an advanced form of AMD such as GA.2,3

Early AMD—marked by white arrows—is associated with multiple small (<63 µm) and a few intermediate (63-124 µm) drusen, or retinal pigment epithelium (RPE) abnormalities.6

Intermediate AMD: Degenerative Changes

Intermediate AMD: Degenerative Changes Image courtesy of Dr. Arshad Khanani.
Intermediate AMD: Degenerative Changes Image courtesy of Dr. Arshad Khanani.

Intermediate AMD is associated with extensive intermediate drusen (63-124 µm) or more than 1 large druse (≥125 µm).6 Pigmentary changes are also indicative of intermediate disease. Degenerative changes in the choriocapillaris, RPE, and photoreceptors may also be observed.1,6

Intermediate drusen (white arrows) can be visualized clearly on OCT and CFP.4,7 Pigmentary changes (wedges) visualized on CFP may precede atrophic changes.1,8

Images are from separate patients.

Advanced AMD (GA): Lesion Enlargement

The progression to GA is characterized by the development of atrophic lesions, expansion of individual areas, or coalescence of multiple lesions in the retinal layers. GA can be detected using various imaging modalities, such as OCT, which are commonly available in most clinics.2,3,6

Advanced AMD (GA): Lesion Enlargement Image courtesy of Dr. Mohammad Rafieetary.
Advanced AMD (GA): Lesion Enlargement Image courtesy of Dr. Arshad Khanani.
Advanced AMD (GA): Lesion Enlargement Image courtesy of Dr. David Lally.

Atrophic lesions represent a loss of the RPE, overlying photoreceptors, and underlying choriocapillaris.2 Atrophic regions (white arrows) are represented on CFP, OCT, and FAF.

Images are from separate patients.

Noninvasive Imaging to Identify GA Early

Early diagnosis of GA is critical, as anatomical changes precede visual acuity or visual function changes.1

Optical Coherence Tomography (OCT)

Optical Coherence Tomography (OCT) Image courtesy of Dr. Arshad Khanani.

Intermediate AMD

Optical Coherence Tomography (OCT) Image courtesy of Dr. Arshad Khanani.

Advanced AMD (GA)

Key Features1,3

(1) Degeneration of overlying photoreceptors increases reflectivity below Bruch’s membrane

(2) Hyper-reflective foci correspond to attenuation or disruption of the RPE

(3) Atrophy of the RPE 

(4) Area of choroidal
hypertransmission

Images are from separate patients.

Color Fundus Photography (CFP)

Color Fundus Photography (CFP) Image courtesy of Dr. Arshad Khanani.

Intermediate AMD

Color Fundus Photography (CFP) Image courtesy of Dr. Mohammad Rafieetary.

Advanced AMD (GA)

Key Features1,4,5

(1) Drusen and (2) fundus abnormalities are identifiable as hyperpigmented areas


(3) GA lesion borders are sharply demarcated with increased choroidal vessel visibility (dashed circle)

Images are from separate patients.

Fundus Autofluorescence (FAF)

Fundus Autofluorescence (FAF) Image courtesy of Dr. Arshad Khanani.

Intermediate AMD

Fundus Autofluorescence (FAF) Image courtesy of Dr. David Lally.

Advanced AMD (GA)

Key Features3,9

(1) Reticular pseudodrusen appearing as multiple, clustered, regularly networked, round areas of low-contrast hyperautofluorescence may be prognostic of advancing AMD
(2) Abnormal patterns of hyperautofluorescence surrounding atrophic lesions
(3) Areas of hypo-autofluorescence with sharply demarcated borders indicate atrophic lesions

Images are from separate patients.

Monitoring for Progression Is Critical

Lesion patterns can be predictive of slower or faster progressing disease and provide key data to inform management strategies.2,6 Patients can present with a wide range of visual symptoms; therefore, it is critical to monitor patients for disease progression.1,9

Monitoring for Progression Is Critical
Monitoring for Progression Is Critical
Monitoring for Progression Is Critical
Focality

Lesion size, location, and focality may be predictive of the rate
of lesion progression in GA. GA progression is faster in lesions that
are larger, outside of the fovea, or multifocal.2,6


References:

  1. Sadda SR, Chakravarthy U, Birch DG, Staurenghi G, Henry EC, Brittain C. Clinical endpoints for the study of geographic atrophy secondary to age-related macular degeneration. Retina. 2016;36(10):1806-1822.

  2. Boyer DS, Schmidt-Erfuth U, van Lookeren Campagne M, Henry EC, Brittain C. The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target. Retina. 2017;37(5):819-835.

  3. Holz FG, Schmitz-Valckenberg S, Fleckenstein M. Recent developments in the treatment of age-related macular degeneration. J Clin Invest. 2014;124(4):1430-1438.

  4. Mones J, Garcia M, Biarnes M, Lakkaraju A, Ferraro L. Drusen ooze: a novel hypothesis in geographic atrophy. Ophthalmol Retina. 2017;1(6):461-473.

  5. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol. 2003;48(3):257-293.

  6. Fleckenstein M, Mitchell P, Freund KB, et al. The progression of geographic atrophy secondary to age-related macular degeneration. Ophthalmology. 2018;125(3):369-390.

  7. Sadda SR, Guymer R, Holz FG, et al. Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3. Ophthalmology. 2018;125(4):537-548.

  8. Garrity ST, Sarraf D, Freund KB, Sadda SR. Multimodal imaging of nonneovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2018;59(4):AMD48-AMD64.

  9. Sunness JS, Rubin GS, Applegate CA, et al. Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity. Ophthalmology. 1997;104(10):1677-1691.